Dendritic cell therapy (Institute of Cellular Therapies)

N/A

Report date: 2025/03/31 17:25:06

Base Information

Drug NameDendritic cell therapy (Institute of Cellular Therapies)
Drug Alias NameDenvax
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cellular Therapies
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Cellular Therapies
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A